Last-line antibiotics are failing: options to address this urgent threat to patients and healthcare systems


The emergence and spread of highly-resistant bacteria,
especially those resistant to ‘last-line’ antibiotics, such as
carbapenems and colistin, is a grave public health concern
and a threat to patient safety and economies in Europe
and globally.